SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-189610
Filing Date
2023-07-19
Accepted
2023-07-19 16:02:09
Documents
15
Period of Report
2023-07-14
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d529233d8k.htm   iXBRL 8-K 31284
2 EX-10.1 d529233dex101.htm EX-10.1 72264
3 EX-99.1 d529233dex991.htm EX-99.1 22653
7 GRAPHIC g529233g0719204012745.jpg GRAPHIC 3793
  Complete submission text file 0001193125-23-189610.txt   279251

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA meip-20230714.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230714_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230714_pre.xml EX-101.PRE 11266
9 EXTRACTED XBRL INSTANCE DOCUMENT d529233d8k_htm.xml XML 3341
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 231096701
SIC: 2834 Pharmaceutical Preparations